These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11599274)

  • 1. [How to overcome antibiotic resistance of Helicobacter pylori. Role of de-nol in current schemes of eradication therapy].
    Kalinin AV
    Ter Arkh; 2001; 73(8):73-5. PubMed ID: 11599274
    [No Abstract]   [Full Text] [Related]  

  • 2. [Eradication of Helicobacter pylori infection. A new therapy standard for duodenal ulcer].
    Caspary WF; Braden B
    Internist (Berl); 1996 Dec; 37(12):1204-11. PubMed ID: 9081921
    [No Abstract]   [Full Text] [Related]  

  • 3. [Characteristics of the effects of de-nol on the course of erosive-ulcerative lesions of the esophagus, stomach and duodenum associated with Helicobacter pylori].
    Grebenev AL; Miagkova LP; Golochevskaia VS; Lapina TL; Sklianskaia OA
    Klin Med (Mosk); 1995; 73(2):34-7. PubMed ID: 7609414
    [No Abstract]   [Full Text] [Related]  

  • 4. [The impact of the degree of Helicobacter pylori semination of the mucous coat of stomach in patients with duodenal ulcer on the infectious organism's eradication].
    Kas'ianenko VI
    Eksp Klin Gastroenterol; 2004; (3):19-23, 102. PubMed ID: 15560395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori positive resistant duodenal ulcers.
    Guslandi M
    Gut; 1993 Nov; 34(11):1646-7; author reply 1647-8. PubMed ID: 8244159
    [No Abstract]   [Full Text] [Related]  

  • 6. [A consensus on some problems of Helicobacter pylori (draft)].
    Zhonghua Nei Ke Za Zhi; 1997 Jul; 36(7):438-9. PubMed ID: 10436941
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of nizatidine, clarithromycin and bismuth subcitrate therapy for Helicobacter pylori eradication in duodenal ulcer patients--a preliminary report.
    Papp J; Juhasz L; Lakatos L; Lonovits J; Szekely I; Tarnok F; Tulassay Z; Varkonyi T
    Br J Clin Pract; 1996; 50(5):249-53. PubMed ID: 8794601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sucralfate and Helicobacter pylori.
    Terano A; Shimada T; Hiraishi H
    J Gastroenterol; 1996 Nov; 31 Suppl 9():63-5. PubMed ID: 8959523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The rational use of De-Nol in the treatment of peptic ulcer and chronic active gastroduodenitis associated with Helicobacter pylori].
    Grigor'ev PIa; Isakov VA; Iakovenko EP; Soluianova IP
    Ter Arkh; 1992; 64(8):101-4. PubMed ID: 1440381
    [No Abstract]   [Full Text] [Related]  

  • 10. Peptic ulcer treatment today--is there a role for maintenance therapy?
    Breslin NP; O'Morain C
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):116-21. PubMed ID: 9646190
    [No Abstract]   [Full Text] [Related]  

  • 11. H2-receptor antagonists an Helicobacter pylori eradication.
    Lamers CB
    Scand J Gastroenterol Suppl; 1995; 212():126-7. PubMed ID: 8578225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cure of Helicobacter pylori: a hidden curse?
    Srinivasan R; Minocha A
    Am J Gastroenterol; 1997 Dec; 92(12):2313-4. PubMed ID: 9399784
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cost-effectiveness of the eradication of Helicobacter pylori in the treatment of duodenal ulcer].
    Domínguez Muñoz JE
    An Med Interna; 1998 Oct; 15(10):513-4. PubMed ID: 9844224
    [No Abstract]   [Full Text] [Related]  

  • 14. A four-year follow-up of duodenal ulcer patients after Helicobacter pylori eradication.
    Tepes B; Kavcic B; Gubina M; Krizman I
    Hepatogastroenterology; 1999; 46(27):1746-50. PubMed ID: 10430336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modern policy of anti-helicobacter therapy of ulcer disease].
    Ryss ES
    Klin Med (Mosk); 1998; 76(10):7-11. PubMed ID: 9865008
    [No Abstract]   [Full Text] [Related]  

  • 16. [Helicobacter pylori and chronic ulcer disease].
    Gustavsson S; Engstrand L
    Lakartidningen; 1991 Feb; 88(8):624-5. PubMed ID: 2002726
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of failure of Helicobacter pylori eradication and predictors of ulcer recurrence: a randomized controlled trial.
    Fallone CA; Loo V; Joseph L; Barkun J; Kostyk R; Barkun AN
    Clin Invest Med; 1999 Oct; 22(5):185-94. PubMed ID: 10579057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori eradication and reinfection.
    Bell GD; Powell KU
    Lancet; 1995 Jun; 345(8965):1646; author reply 1647-8. PubMed ID: 7632295
    [No Abstract]   [Full Text] [Related]  

  • 19. Sucralfate in Helicobacter pylori eradication strategies.
    Lam SK; Hu WH; Ching CK
    Scand J Gastroenterol Suppl; 1995; 210():89-91. PubMed ID: 8578217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term eradication therapy for Helicobacter pylori does not reduce the incidence of gastric metaplasia in duodenal ulcer patients.
    Rudnicka L; Bobrzyński A; Stachura J
    Pol J Pathol; 1997; 48(2):103-6. PubMed ID: 9278106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.